March 1, 2018 / 1:51 PM / 6 months ago

BRIEF-Aratana Therapeutics Expands Therapeutic Candidate Pipeline

March 1 (Reuters) - Aratana Therapeutics Inc:

* ARATANA THERAPEUTICS EXPANDS THERAPEUTIC CANDIDATE PIPELINE

* ARATANA THERAPEUTICS INC - ANNOUNCED AN ANIMAL HEALTH RESEARCH AND DEVELOPMENT COLLABORATION WITH ASKAT INC

* ARATANA THERAPEUTICS INC - LICENSED EXCLUSIVE, WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE AT-019, KNOWN AS AAT-008 BY ASKAT

* ARATANA THERAPEUTICS INC - AT-019 LICENSE AGREEMENT INCLUDES AN UPFRONT PAYMENT OF $0.5 MILLION; MILESTONE PAYMENTS OF UP TO $15.5 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below